The 2014-15 fellowship has passed the halfway mark and the three fellowship teams are deep into concept refinement and testing. This year’s cohort comprises six physicians and six engineers with a mix of clinical, business, and research backgrounds. Each of the twelve fellows arrived at Biodesign with some prior work in medical devices and each carried certain expectations about the process. In this post, six fellows discuss their prior expectations, the surprises they encountered, and how their expectations have shifted during the year.
SBAA asked these six fellows to answer the following question:
What’s the most surprising thing you’ve learned about the medtech innovation process since you started the fellowship?
Their responses are below.
MedtechWomen (http://medtechwomen.org/) is an organization bringing talented women together and highlighting female medtech leaders. On February 13th 2013, fifteen Biodesign fellows and alumni had the chance to meet with three of the organization’s leaders — Amy Belt, MBA (Director, Covidien Ventures), Deb Kilpatrick, PhD (Chief Commercial Officer, CardioDx) and Bridget Hurley, MS (Director of R&D, Abbott). This is a summary highlighting the discussion.
Why do women rarely headline medtech conferences? Amy Belt pondered this question in the spring of 2009, looking out to a sea of navy blue blazers and calculating only 4% of the podium speakers at her three previous conferences were women. She was bothered that “it gave a visual that the experts were not women. That simply wasn’t true.” Read more
Mid-Year Reflections from 10th Class of Biodesign Fellows
Knowing is not enough; we must apply. Being willing is not enough; we must do.
– Leonardo da Vinci
The fellows are now over 4 months into the Biodesign Innovation Fellowship, and we have been striving to put Leo’s words into practice. Reading or just talking about how to innovate new medical technologies is not enough. We must do.
Each of us came into the program with a unique set of experiences and expectations. Reflecting on our progress thus far at about the midpoint through the year, the fellows were tasked with answering the following question:
In one paragraph: what was the most challenging aspect of transitioning from your previous life (engineer, physician, or researcher) to jumping into the Biodesign innovation process?